Julie Brahmer, MD of Johns Hopkins Kimmel Comprehensive Cancer Center explains how this clinical trial now allows clinicians and other healthcare professionals to quote five-year data to patients with non-small cell lung cancer. She argues the impact of this data will give hope to lung cancer patients of their options. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.
Trial Now Allows Clinicians to Quote Five-Year Data to Patients
